Scientists, industry and government are doing their bit to develop the Australian biotechnology industry, writes Peter Andrews -- so where are the investors? [ + ]

Australian Biotechnology News editor-in-chief Iain Scott spoke with renowned industry analyst Cynthia Robbins-Roth about what it will take to keep biotech alive. [ + ]

A team of scientists, led by researchers at The University of Nottingham, is studying the secret sex life of a fungus that causes potentially life-threatening infections in an effort to find new ways of controlling the disease

Growth of certain adherent cell lines can be problematic due to poor attachment to traditional tissue culture treated surfaces. This article demonstrates the use of the Corning CellBind Surface to improve the recovery and yield of LNCaP cells

Nature can assemble complex structures in a single step so why can't we? Well we can, if we know enough about supramolecular chemistry and bring together the right ingredients

Researchers at the Australian Research Council Centre of Excellence in Biotechnology and Development, are rapidly gaining ground on the mysteries of male infertility and progressing the development of a reversible male contraceptive

After a recent first-hand look, Russell McInnes shares some perspectives on India's burgeoning biotech industry. [ + ]

Producing products from human blood plasma is a lucrative business and the Chinese market provides a significant long-term opportunity, AVT Plasma's CEO tells Ruth Beran. [ + ]

Peter Beattie talks to Graeme O'Neill about his vision of the future for Queensland bioscience. [ + ]

State government policy has been vital in helping to shape the Australian biotechnology industry. Here, Cristy Burne takes us for a tour of Western Australia, the state that later this year will host the national biotech conference. [ + ]

There's no tyranny in distance for some globetrotting Australian biotechnology companies, writes Michael Vitale [ + ]

Opened by the Victorian premier earlier this month, the Bio21 Institute provides a structure in which research, business incubation and commercialisation are all conducted under one collaborative roof, Anne Fletcher reports. [ + ]

The nanotech sector in Australia is growing with potential. [ + ]

Is RNAi the real deal? Graeme O'Neill asked Australian scientist and global authority John Mattick. [ + ]

Keith Williams reflects on the long and winding road he has travelled as a player in the filed of protein science. [ + ]